M.S. patients who use neurology and neuropsychiatry clinics in Canada also report a high frequency of use, the study adds. With only cognitively impaired individuals taking part in the review, participants were assigned to a cannabis continuation (CC) or cannabis withdrawal (CW) group. Self-awareness may be inaccurate,” study authors note. Supported in part by the Multiple Sclerosis Society of Canada, the study followed 40 people with M.S. for 28 days who reported smoking cannabis almost daily. The researchers point out that cannabis use is very common among people with M.S. Citing a 2017 survey hosted by the National M.S. Society and the Michael J. Fox Foundation, the results show two-thirds of respondents with M.S. were currently using cannabis, almost double the figure for those with Parkinson’s disease.
The inability of people with multiple sclerosis (MS) to accurately appraise their memory and executive function partly explains why they continue to smoke cannabis “despite objective evidence of the deleterious cognitive side effects of this behaviour,” suggests a Canadian study.
Supported in part by the Multiple Sclerosis Society of Canada, the study followed 40 people with M.S. for 28 days who reported smoking cannabis almost daily. With only cognitively impaired individuals taking part in the review, participants were assigned to a cannabis continuation (CC) or cannabis withdrawal...
Read the full article @ The Growth Op